AI-generated summary
The authors describe a single 47-year-old woman with Reed Syndrome and 361 cutaneous leiomyomas, treated with fully ablative Erbium:YAG laser resurfacing after standard therapies failed. One year later, they report repigmentation, no recurrence of lesions and no associated pain. As a single case report, the findings cannot establish how well this treatment works for others.
- Participants
- 1
- Who or what was studied
- One 47-year-old female with Reed Syndrome and an unusually extensive cutaneous leiomyoma burden
- Limits stated in the abstract
- The report describes a single patient with one year of follow-up and no control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.